NASDAQ
American Oriental Bioengineering, Inc. (AOBI) has a free cash flow growth of -662.53% as of Friday, May 29, 2026. This represents a 631.87% decrease compared to its 12-month average of -90.53%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.